person · Reporting owner
Sestrick Michael Robert
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | SVP & Chief Technology Officer | February 12, 2025 | February 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 12, 2025 · Filed February 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,762 |
Ending reported balance
After 2025-02-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-02-13 · Grant · Acquired 2,016 · Balance 5,807 F1: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2022-2024 performance period. Row 2 · 2025-02-13 · Tax withholding · Disposed 1,045 · Balance 4,762 F2: 1,045 of the 2,016 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 848 |
Reported balance
Holding disclosure · report date 2025-02-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 848 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2022-2024 performance period.
F2: 1,045 of the 2,016 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2025 Filed Feb 14, 2025 22:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,045 | $163.14 | $170,481.30 |
DisclosureSEC source: 0001140361-25-004905 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,762 F2 · shares: 1,045 of the 2,016 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004905 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,807 F1 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 305 | $159.39 | $48,613.95 |
DisclosureSEC source: 0001140361-25-004097 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,791 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/10/2022). Read SEC document |
| May 10, 2024 Filed May 13, 2024 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 1,929 | $154.45 | $297,934.63 |
DisclosureSEC source: 0001140361-24-025706 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,878 F1 · price: This transaction was executed in multiple sales ranging from $154.3700 to $154.8800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 3,700 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · derivative · entry 7 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,700 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · derivative · entry 6 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 3,900 | $0.00 Strike: $76.89 | $0.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · derivative · entry 5 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,900 shares Expires 2027-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options that vested 20% on April 18, 2018, 40% on April 18, 2019, and 40% on April 18, 2020, and are exercisable. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 11,100 | $153.21 | $1,700,613.24 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · nonDerivative · entry 4 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,736 F2 · price: This transaction was executed in multiple sales ranging from $152.7200 to $153.6600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 3,700 | $84.09 | $311,133.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · nonDerivative · entry 3 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 3,500 | $74.57 | $260,995.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 3,900 | $76.89 | $299,871.00 |
DisclosureSEC source: 0001140361-24-009273 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:48 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 312 | $145.33 | $45,342.96 |
DisclosureSEC source: 0001140361-24-007473 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,736 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,000 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · derivative · entry 4 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,104 | $143.43 | $158,346.72 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 3 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,048 F4 · shares: 1,104 of the 2,069 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,152 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,083 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,300 | $130.36 | $299,836.74 |
DisclosureSEC source: 0001140361-23-022963 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,424 F1 · shares: This transaction was executed in multiples sales ranging from $129.9700 to $130.9000 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 278 | $135.67 | $37,716.26 |
DisclosureSEC source: 0001140361-23-007248 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,618 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,000 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · derivative · entry 4 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 999 | $138.09 | $137,951.91 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 3 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,896 F4 · shares: 999 of the 2,163 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,895 F3 · shares: Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 580 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006115 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,732 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.